Latest news with #MiraeAssetMutualFund
Time of India
11-07-2025
- Business
- Time of India
Glenmark Pharmaceuticals shares rally up to 20%, mutual funds lead the charge over retail investors
The shares of Glenmark Pharmaceuticals surged 20% on Friday, July 11, to a day's high of Rs 2,286 following a landmark $2 billion licensing deal with U.S. pharma giant AbbVie for its cancer drug, ISB 2001. While the announcement caught the attention of retail investors, the real winners were India's top mutual funds . pradee According to the data on BSE, mutual fund holdings in Glenmark Pharma rose from 9.11% in June 2023 to 14.60% by March 2025 (the last available data). Best MF to invest Looking for the best mutual funds to invest? Here are our recommendations. View Details » by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Live by the Beach at Sunteck's 2/3BHK Homes starts @₹98L+ Sunteck Realty Learn More Undo Also Read | Investors' pour Rs 47,000 crore in midcap & smallcap mutual funds in H1 CY25. What are they really chasing? Promoters hold around 46% and FIIs hold around 23.16% as on March 2025, according to the last available data on BSE. Public shareholding data shows that the retail investors' holding has declined from 9.99% in June 2023 to 7.69% in March 2025 (individual shareholders holding nominal share capital up to Rs 2 lakh) Live Events According to the last available data, Prashant Jain's 3P India Equity Fund held nearly 1.02% in Glenmark, while Ashish Dhawan held 1.77% in this stock. Mutual funds holding Mutual funds had around 4.16 crore shares of Glenmark Pharmaceuticals in May worth Rs 6,072 crore. Around 27 mutual fund houses had this stock in their portfolio as on May 31, 2025. Out of 27 AMCs, HDFC Mutual Fund and Mirae Asset Mutual Fund had the highest number of shares in their respective portfolios. HDFC Mutual Fund had around 1.27 crore shares of Glenmark Pharmaceuticals worth Rs 1,863 crore in May followed by Mirae Asset Mutual Fund which had 1.01 crore shares of this stock worth Rs 1,473 crore. Around 13 funds from HDFC Mutual Fund had this stock in their portfolio, of which HDFC Mid Cap Fund had the highest number of shares of around 87.78 lakh worth Rs 1,279 crore, followed by HDFC Manufacturing Fund which had 12 lakh shares of this stock worth Rs 174 crore. Around 17 funds from Mirae Asset Mutual Fund had exposure in this stock with Mirae Asset Large & Midcap Fund having the highest number of shares of 33.13 lakh worth Rs 482 crore. Mirae Asset Nifty Total Market Index Fund had the lowest number of shares of 319 in its portfolio. Also Read | How much money did ICICI Prudential's star fund manager Sankaran Naren make in FY25? Kotak Mutual Fund had 19.66 lakh shares of Glenmark Pharmaceuticals in its portfolio worth Rs 286 crore. Eight funds from the fund house had this stock in their portfolio and Kotak Arbitrage Fund had the highest number of shares of 13.48 lakh. SBI Mutual Fund , the largest mutual fund house based on assets managed, had 4.98 lakh shares of this stock worth Rs 72 crore, followed by Motilal Oswal Mutual Fund which had 2.49 lakh shares worth Rs 36.29 crore. PPFAS Mutual Fund had 3,575 shares in its portfolio worth Rs 0.52 crore. Angel One Mutual Fund and Unifi Mutual Fund which are new entrants in the mutual fund industry had around 453 and 325 shares of this stock in their respective portfolios. FII's holding According to the last available data, FII's holding showed a mixed trend. Smallcap World Fund, INC had 3.21% holding in this stock compared to 4.52% in June 2023. Government Pension Fund Global had 3.25% holding in March 2025 compared to 2.26% in June 2023. Ellipsis Partners LLC had 1.11% exposure in this stock compared to 1.68% in June 2023. Glenmark Pharmaceuticals step-down wholly owned subsidiary, Ichnos Glenmark Innovation (IGI), signed an exclusive global licensing agreement with US-based AbbVie for its experimental cancer drug, ISB 2001. ISB 2001, currently in Phase 1 clinical trials for relapsed or refractory multiple myeloma, will be jointly developed under the deal. AbbVie will hold exclusive rights to develop, manufacture, and commercialise the drug in North America, Europe, Japan, and China. Meanwhile, Glenmark will retain rights for Emerging Markets, including Asia (excluding Japan and China), Latin America, Russia/CIS, the Middle East, Africa, Australia, New Zealand, and South Korea. Under the agreement, IGI Therapeutics SA—a subsidiary of Ichnos Glenmark Innovation—will receive a $700 million upfront payment and is eligible for up to $1.225 billion in milestone payments, along with tiered, double-digit royalties on net sales.
Economic Times
11-07-2025
- Business
- Economic Times
Glenmark Pharmaceuticals shares rally up to 20%, mutual funds lead the charge over retail investors
The shares of Glenmark Pharmaceuticals surged 20% on Friday, July 11, to a day's high of Rs 2,286 following a landmark $2 billion licensing deal with U.S. pharma giant AbbVie for its cancer drug, ISB 2001. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Mutual funds holding Tired of too many ads? Remove Ads FII's holding The shares of Glenmark Pharmaceuticals surged 20% on Friday, July 11, to a day's high of Rs 2,286 following a landmark $2 billion licensing deal with U.S. pharma giant AbbVie for its cancer drug, ISB the announcement caught the attention of retail investors, the real winners were India's top mutual funds . pradeeAccording to the data on BSE, mutual fund holdings in Glenmark Pharma rose from 9.11% in June 2023 to 14.60% by March 2025 (the last available data).Also Read | Investors' pour Rs 47,000 crore in midcap & smallcap mutual funds in H1 CY25. What are they really chasing? Promoters hold around 46% and FIIs hold around 23.16% as on March 2025, according to the last available data on BSE. Public shareholding data shows that the retail investors' holding has declined from 9.99% in June 2023 to 7.69% in March 2025 (individual shareholders holding nominal share capital up to Rs 2 lakh)According to the last available data, Prashant Jain's 3P India Equity Fund held nearly 1.02% in Glenmark, while Ashish Dhawan held 1.77% in this funds had around 4.16 crore shares of Glenmark Pharmaceuticals in May worth Rs 6,072 crore. Around 27 mutual fund houses had this stock in their portfolio as on May 31, of 27 AMCs, HDFC Mutual Fund and Mirae Asset Mutual Fund had the highest number of shares in their respective portfolios. HDFC Mutual Fund had around 1.27 crore shares of Glenmark Pharmaceuticals worth Rs 1,863 crore in May followed by Mirae Asset Mutual Fund which had 1.01 crore shares of this stock worth Rs 1,473 13 funds from HDFC Mutual Fund had this stock in their portfolio, of which HDFC Mid Cap Fund had the highest number of shares of around 87.78 lakh worth Rs 1,279 crore, followed by HDFC Manufacturing Fund which had 12 lakh shares of this stock worth Rs 174 17 funds from Mirae Asset Mutual Fund had exposure in this stock with Mirae Asset Large & Midcap Fund having the highest number of shares of 33.13 lakh worth Rs 482 crore. Mirae Asset Nifty Total Market Index Fund had the lowest number of shares of 319 in its Read | How much money did ICICI Prudential's star fund manager Sankaran Naren make in FY25? Kotak Mutual Fund had 19.66 lakh shares of Glenmark Pharmaceuticals in its portfolio worth Rs 286 crore. Eight funds from the fund house had this stock in their portfolio and Kotak Arbitrage Fund had the highest number of shares of 13.48 lakh. SBI Mutual Fund , the largest mutual fund house based on assets managed, had 4.98 lakh shares of this stock worth Rs 72 crore, followed by Motilal Oswal Mutual Fund which had 2.49 lakh shares worth Rs 36.29 Mutual Fund had 3,575 shares in its portfolio worth Rs 0.52 crore. Angel One Mutual Fund and Unifi Mutual Fund which are new entrants in the mutual fund industry had around 453 and 325 shares of this stock in their respective to the last available data, FII's holding showed a mixed trend. Smallcap World Fund, INC had 3.21% holding in this stock compared to 4.52% in June 2023. Government Pension Fund Global had 3.25% holding in March 2025 compared to 2.26% in June 2023. Ellipsis Partners LLC had 1.11% exposure in this stock compared to 1.68% in June Pharmaceuticals step-down wholly owned subsidiary, Ichnos Glenmark Innovation (IGI), signed an exclusive global licensing agreement with US-based AbbVie for its experimental cancer drug, ISB 2001, currently in Phase 1 clinical trials for relapsed or refractory multiple myeloma, will be jointly developed under the deal. AbbVie will hold exclusive rights to develop, manufacture, and commercialise the drug in North America, Europe, Japan, and China. Meanwhile, Glenmark will retain rights for Emerging Markets, including Asia (excluding Japan and China), Latin America, Russia/CIS, the Middle East, Africa, Australia, New Zealand, and South the agreement, IGI Therapeutics SA—a subsidiary of Ichnos Glenmark Innovation—will receive a $700 million upfront payment and is eligible for up to $1.225 billion in milestone payments, along with tiered, double-digit royalties on net sales.
Time of India
16-06-2025
- Business
- Time of India
NFO Alert: Mirae Asset Mutual Fund launches Nifty India Internet ETF
Mirae Asset Mutual Fund has announced the launch of the Mirae Asset Nifty India Internet ETF , an open-ended scheme that replicates/tracks the Nifty India Internet Total Return Index. The New Fund Offer (NFO) for the Mirae Asset Nifty India Internet ETF will open for subscription on June 18 and close on June 25. The fund will reopen for continuous sale and repurchase on July 2. This thematic ETF offers investors an opportunity to participate in India's growing internet-based business ecosystem through a diversified portfolio of companies that derive a significant portion of their revenues from online platforms. Best MF to invest Looking for the best mutual funds to invest? Here are our recommendations. View Details » by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like An engineer reveals: 1 simple trick to get all TV channels Techno Mag Learn More Undo The Nifty India Internet Index is designed to capture the performance of companies operating primarily in the internet domain, including segments such as e-commerce, fintech, web-based media and services, online travel, food delivery, digital entertainment, etc., selected from the Nifty Total Market Index. The index comprises a mix of large, mid, and small-cap companies, with a strong representation of emerging and digitally focused businesses, according to a press release. The scheme will be managed by Ekta Gala and Akshay Udeshi. The minimum initial investment during the NFO period will be Rs 5,000, and in multiples of Re 1 thereafter. Live Events 'India's digital economy is not just growing—it is reshaping how businesses operate and how consumers engage. With the launch of the Mirae Asset Nifty India Internet ETF , we are continuing our endeavour to provide investors access to structural, long-term themes through simple and transparent vehicles like ETFs. This product aligns with our view that thematic investing can be a meaningful part of building a future-ready portfolio,' said Swarup Anand Mohanty, Vice Chairman & CEO, Mirae Asset Investment Managers (India). The Nifty India Internet Index includes companies that have a significant reliance on digital and online business models, reflecting the broader internet economy in India. The index is reconstituted semi-annually and rebalanced quarterly. Currently, the index comprises 21 stocks, with the top stock capped at 20% at the time of rebalancing. The portfolio is expected to evolve as more digital and online-centric companies get listed and become part of the eligible universe. 'The Mirae Asset Nifty India Internet ETF is designed to reflect the shift in India's consumption and business landscape, where digital platforms are becoming central to engagement, delivery, and growth. By offering exposure to this evolving theme through an ETF, we aim to provide access to a diversified basket of businesses that are driving India's ongoing digital transformation,' said Siddharth Srivastava , Head – ETF Products, Mirae Asset Investment Managers (India).
Mint
11-05-2025
- Business
- Mint
What makes Mirae Asset's Swarup Mohanty paranoid about his retirement corpus
Swarup Mohanty, 54, chief executive officer of Mirae Asset Mutual Fund, is 'paranoid" about his retirement corpus. 'People are going to live longer. Most people plan for life till 80 post-retirement. If they start to live beyond that and there is no planning for that, it can start to really pinch. Besides this, if I have worked so hard during my working life, I should have a better life in my retirement. So, it is important for me to plan for a larger retirement kitty to take care of my inflation-adjusted lifestyle expenses," Mohanty said. Mohanty says these factors have prompted him to target a higher retirement corpus. 'I have crossed the minimum target on my retirement corpus. As these are the last years of my accumulation phase, I want to make most of it by continuing my investments and even take tactical calls, and get as close as possible to my new target," Mohanty said in an interaction with Mint on 'Guru Portfolio', a series where leaders from the financial services industry share how they manage their money. Investment mix Mohanty maintains an asset allocation mix of 70% in equities, 20% in debt and 10% in alternates. The alternate pie includes his investments in art and startups. Over the past 12 months, his portfolio has delivered returns of 6%, while over the past five-year period, it has returned 23% annualized returns. Mohanty says what worked for his portfolio over the past year was his large-cap exposure. "Large-cap funds outperformed their respective benchmark indices. Thematic investments such as healthcare and banking also did well." Also Read: Should you diversify your portfolio by adding mutual funds focused on quality strategy? Within his equity portfolio, Mohanty's market-cap split is largely skewed towards large-caps and mid-caps. He attributes this to his heavy exposure to Mirae Asset MF's Large- and Mid-Cap Fund. His large- and mid-cap fund exposure is 50%, while pure mid-cap and thematic funds account for the remaining 50%. He is betting on themes such as manufacturing, healthcare and banking. 'These themes are a long-term structural play in India," he said. So far, Mohanty says, he has avoided small-caps to avoid high volatility in his retirement-linked investments, but he may add some small-caps. 'After the correction, there are opportunities in the small-cap space." As mentioned earlier, Mohanty wants to be more tactical with his investments. He pointed out that he missed the gold rally over the past year (despite his bullish view), just to stick to his asset allocation grid. 'I have realized I need to be more vigilant of tactical opportunities and act on them in a timely manner." Mohanty has one-fourth of his equity exposure through passive funds. His passive fund investments include a factor-based fund, an international fund and banking & financial services fund, among others. About 80-85% of his mutual fund portfolio is invested in Mirae Asset MF's schemes. He says that he looks for non-Mirae schemes for style diversification. Alternatives Mohanty's alternate investments are spread across art and startups. Art investments account for 65% of his alternate portfolio, while 35% is in startups. His startup bets include a health tech startup and a regional-content OTT platform for Oriya-language content. As Mohanty himself originally hails from Odisha, he said the pitch appealed to him. Also Read: After large-cap switch last year, Quant MF's Sandeep Tandon starts to add small-caps He says his art investments are fully handled by his wife. 'She does all the research on the artists and art types that we should add to our portfolio. By now, she has created a wishlist and we add to our collection as and when there is an opportunity. Last year, we added another art piece from a 'master'," he said. Unlike market-linked investments such as mutual funds or ETFs, where price discovery happens on a minute-by-minute basis, how does Mohanty and his wife evaluate their art investments? 'Once you get into that circuit and you know the good galleries in the country, there is a broad consensus on the prices of each painter. Admittedly, it is not a very liquid market, but I am also not buying to sell in the near future," Mohanty said. According to Mohanty, alternates give his portfolio another dimension, but these are high risk, high return investments. He said he will not go beyond 10% on alternates in his overall portfolio, given these investments have lower liquidity. Insurance and contingency Mohanty has a large family health cover of ₹3.75 crore. 'I have seen ₹25 lakh of my savings just going for my father's medical expenditure. After this, I have tried to take as much medical insurance as I can for my family. I have got ₹3.75 crore medical cover for my family; ₹3 crore for my wife and I, and a separate ₹75-lakh health cover for my son," he said. Mohanty believes that life insurance should take care of debt and potential earnings of the earning member, as much as possible. So, he has three times his debt (home loan: ₹4 crore) for his term life cover, which is about ₹12 crore. He recently upgraded his house as his son has decided to stay with them instead of going abroad for work. This purchase was partly funded by the sale of his previous house and his Nifty 50 ETF investments. Also Read: Why Marcellus' Saurabh Mukherjea has 40% global weight 'As a net effect, my home loan is the same as what I was carrying for my previous house as of last year," he said. However, he doesn't maintain a separate contingency fund now. 'Now, my equity gains are large enough to meet any contingency requirements and can be easily liquidated, if needed. However, large insurance covers are also in place," Mohanty said. Travel goals Mohanty is an avid traveller. Next, he plans to visit the idyllic villages of England and says he would like to drive there. He plans for his travel expenses at the beginning of the year by parking the required funds in a liquid fund. Keeping finances in check Mohanty says he likes to track his expenses on a monthly basis, which helps him maintain his savings rate. He keeps his savings rate at 35%. He has been compiling a net worth statement annually for the past several years, which helps him keep him on track towards his financial goals.
Time of India
30-04-2025
- Business
- Time of India
NFO Alert: Mirae Asset Mutual Fund launches Nifty50 Equal Weight ETF
Mirae Asset Mutual Fund has launched the New Fund Offer (NFO) for the Mirae Asset Nifty50 Equal Weight ETF , an open-ended scheme replicating/tracking the Nifty50 Equal Weight Total Return Index. According to a release by the fund house, the ETF aims to offer investors equal-weighted exposure across all Nifty 50 stocks. #Pahalgam Terrorist Attack Pakistan's General Asim Munir is itching for a fight. Are his soldiers willing? PM Modi chairs 'Super Cabinet' meeting after giving army 'full freedom' India planning to launch military strike against Pakistan within 24 to 36 hours, claims Pak minister The NFO is currently open for subscription and will close on May 6. The scheme will reopen for continuous sale and repurchase from May 12. During the NFO period, the minimum initial investment is Rs 5,000, with subsequent investments in multiples of Re 1. The fund will be jointly managed by Ekta Gala and Akshay Udeshi. Play Video Pause Skip Backward Skip Forward Unmute Current Time 0:00 / Duration 0:00 Loaded : 0% 0:00 Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 1x Playback Rate Chapters Chapters Descriptions descriptions off , selected Captions captions settings , opens captions settings dialog captions off , selected Audio Track Picture-in-Picture Fullscreen This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Text Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Transparent Caption Area Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Drop shadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. Best MF to invest Looking for the best mutual funds to invest? Here are our recommendations. View Details » by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo Also Read | MF Tracker: HDFC Small Cap Fund turns Rs 10,000 SIP to Rs 1.14 crore in 17 years The Nifty50 Equal Weight Index assigns equal weight (~2%) to all Nifty 50 large-cap stocks, reducing concentration risk in individual stocks and offering better diversification. This structure gives relatively more weight to tail-end stocks, making the index more representative of broader market trends, the release noted. Live Events The index tends to exhibit cyclical performance—potentially outperforming during broad-based market rallies but underperforming during corrections or when markets are led by a few large-cap names. 'This ETF seeks to capitalise on opportunities in the large-cap segment during phases of broad-based economic growth, by providing equal opportunity to each company in the Nifty 50,' said Siddharth Srivastava, Head – ETF Products and Fund Manager, Mirae Asset Investment Managers (India). Also Read | Akshaya Tritiya: How gold ETFs performed in last 10 calendar years Investors looking for more diversified exposure to Nifty 50 stocks—with lower concentration in top constituents and increased participation from tail stocks—may find this strategy appealing. It is particularly suited for periods of broad market participation, when gains are more evenly distributed across sectors and companies.
